<PAGE> 1

-----------------------------------------------------------------
-----------------------------------------------------------------


                SECURITIES AND EXCHANGE COMMISSION
                     Washington, D. C.   20549
                ----------------------------------

                             FORM 10-Q

[ x ]     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
          SECURITIES EXCHANGE ACT OF 1934

          For the quarterly period ended December 31, 1999.

[   ]     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
          SECURITIES EXCHANGE ACT OF 1934
          For the transition period from:

                  ------------------------------
                  Commission file number 0-27094
                  ------------------------------

                  FIRST AMERICAN SCIENTIFIC CORP.
      (Exact name of Registrant as specified in its charter.)

NEVADA                             88-0338315
(State of other jurisdiction of    (IRS Employer
incorporation or organization)     Identification No.)

                  409 Granville Street, Suite 1003
               Vancouver, British Columbia   V6C 1T2
   (Address of principal executive offices, including zip code.)

                           (604) 681-8656
        Registrant's telephone number, including area code.

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Act of
1934 during the preceding 12 months (or for   such shorter period that
the Registrant was required to file such  reports), and (2) has been
subject to such filing requirements   for the past 90 days. YES [    ]
NO [ x ]

The number of shares outstanding of the Registrant's Common   Stock, no
par value per share, at September 30, 1999 was 66,146,018 shares.

-----------------------------------------------------------------
----------------------------------------------------------------------











<PAGE> 2
                              PART I

ITEM 1.   FINANCIAL STATEMENTS.

FIRST AMERICAN SCIENTIFIC CORP.
BALANCE SHEETS
ASSETS
<TABLE>
<CAPTION>
                                        Dec 31, 1999   June 30, 1999
<S>                                     <C>            <C>
CURRENT ASSETS
 Cash                                   $    75,155    $    25,690
 Accounts receivable                          9,007          9,007
 Prepaid expenses                            53,500             -
                                        -----------    -----------
 TOTAL CURRENT ASSETS                       137,662         34,697
                                        -----------    -----------
INVESTMENTS
 Securities                                   1,010             -
 Other                                      250,219             -
                                        -----------    -----------
                                            251,229             -
                                        -----------    -----------
PROPERTY AND EQUIPMENT
 Ultrasound equipment                       972,246        872,246
 Plant assets and equipment                 687,881        687,881
 Office equipment                            23,916         23,916
 Leasehold improvements                       5,476          5,476
                                        -----------    -----------
                                          1,689,519      1,589,519
 Less: Accumulated depreciation            (327,567)      (327,567)
                                        -----------    -----------
                                          1,361,952      1,261,952
                                        -----------    -----------
OTHER ASSETS
 Technology licenses-net
  of amortization                         1,630,275      1,629,775
 Patents and manufacturing rights-net
  of amortization                           218,265        218,265
 Deposits                                    11,431         11,431
                                        -----------    -----------
                                          1,859,971      1,859,471
                                        -----------    -----------
TOTAL ASSETS                            $ 3,610,814    $ 3,156,120
                                        ===========    ===========
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
 Bank overdraft                         $        -     $        -
 Accounts payable and accrued expenses      265,004        268,061
 Short term loans payable                    24,820             -
 License agreement payable-Spectrasonic
   Corp.                                         -         302,000
                                        -----------    -----------
 TOTAL CURRENT LIABILITIES                  289,824        570,061
                                        -----------    -----------
</TABLE>


   The accompanying notes are an integral part of these financial
                            statements.

                                1-a
<PAGE> 3

FIRST AMERICAN SCIENTIFIC CORP.
BALANCE SHEETS - CONTINUED
<TABLE>
<CAPTION>

                                        Dec 31, 1999   June 30, 1999
<S>                                     <C>            <C>
COMMITMENTS AND CONTINGENCIES                    -              -

STOCKHOLDERS' EQUITY
 Common stock - $.001 par value
  100,000,000 shares authorized,
  97,746,018 and 66,146,018 shares
  issued, respectively                       97,746         66,146
Additional paid-in capital                7,218,450      6,399,031
 Stock options receivable                        -              -
Accumulated deficit                      (3,998,160)    (3,882,072)
Accumulated other comprehensive income        2,954          2,954
                                        -----------    -----------
                                          3,320,990      2,586,059
                                        -----------    -----------
TOTAL LIABILITIES AND
 STOCKHOLDERS' EQUITY                   $ 3,610,814    $ 3,156,120
                                        ===========    ===========

</TABLE>
































    The accompanying notes am an integral pan of these financial
                            statements.

                                1-b
<PAGE> 4

FIRST AMERICAN SCIENTIFIC CORP.
STATEMENTS OF OPERATIONS AND ACCUMULATED DEFICIT
<TABLE>
<CAPTION>
                                   Period Ended   Year Ended
                                   Dec 31, 1999   June 30, 1999
<S>                                <C>            <C>
Revenues                           $       -      $    285,399

Cost of sales                              -           106,595
                                   ----------     ------------
Gross                                      -           178,804

Operating expenses                    113,670          594,993
                                   ----------     ------------
                                     (113,670)        (416,189)

Net loss from operations             (113,670)        (416,189)

Other income (expense)
 Miscellaneous                             -               445
 Loss on impairment of assets              -          (629,118)
                                   ----------     ------------
                                     (113,670)      (1,044,862)
Extraordinary income
 Gain on debt forgiveness                  -            33,767
                                   ----------     ------------
Net loss                             (113,670)      (1,011,095)
Other comprehensive
 Foreign currency translation gain     (2,419)           2,954

Comprehensive income               $ (116,089)    $ (1,008,141)
                                   ==========     ============
Basic and diluted net loss
 per common share                  $    0.003     $       0.02
                                   ==========     ============
Weighted average number of
 common stock shares outstanding   76,760,393       55,876,015
                                   ==========     ============
</TABLE>

















   The accompanying notes are an integral part of these financial
                            statements.

                                 2
<PAGE> 5
FIRST AMERICAN SCIENTIFIC CORP.
STATEMENT OF STOCKHOLDERS' EQUITY
December 31, 1999
<TABLE>
<CAPTION>
                                       Additional                 Total
                     Common Stock      Paid-in      Deficit       Stockholders'
                  Shares      Amount   Capital      Accumulated   Equity
<S>               <C>         <C>      <C>          <C>           <C>
BALANCE Inception
 April 12, 1995            -  $    -   $        -   $       -     $      -

Issuance of stock
 at $0.1667 per
 share for cash     6,000,000   6,000      94,000           -       100,000

Issuance of stock
 at $0.70 per share
 for payment on
 licence agreement    250,000     250     174,750           -      175,000

Net loss for
  the period               -       -           -           (52)        (52)
                    --------- ------- -----------   ----------   ---------
BALANCE
 June 30, 1995      6,250,000   6,250     268,750          (52)    274,941

Issuance of stock
 at $0.45 per share
 for cash             600,000     600     269,400           -      270,000

Issuance of stock
 at $0.50 per share
 in lieu of payment
 on management
 contract             200,000     200      99,800           -      100,000

Issuance of stock
 at $0.50 per share
 for purchase of one
 Gypsum SDM and the
 related technology,
 per agreement      1,000,000  1,000     499,000             -     500,000

Private placement
 sale of stock at
 $1.25 per share
 for cash             74,400      74      92,926             -      93,000

Issuance of stock at
 $0.45 per share in
 settlement of debt
 conversion          380,717     381     170,942             -     171,323

Net loss for the
 year                     -       -           -        (473,369)  (473,369)
                   --------- ------- -----------     ----------  ---------
BALANCE
 June 30, 1996     8,505,117 $ 8,505 $ 1,400,913     $ (473,421) $ 935,902
                   --------- ------- -----------     ----------  ---------
</TABLE>
The accompanying notes are an integral part of these financial statements.

                                  4
<PAGE> 6

FIRST AMERICAN SCIENTIFIC CORP.
STATEMENT OF STOCKHOLDERS' EQUITY
December 31, 1999
<TABLE>
<CAPTION>
                                     Additional                   Total
                   Common Stock      Paid-in       Deficit        Stockholders'
                Shares     Amount    Capital       Accumulated    Equity
<S>             <C>        <C>       <C>           <C>            <C>
BALANCE
 June 30, 1996  8,505,117  $ 8,505   $ 1,400,913   $   (473,421)   $   935,902

Issuance of stock
 at $0.50 per
 share for payment
 technology license
 agreement     1,000,000     1,000       499,000             -         500,000

Issuance of stock
 at $0.40-$0.225
 per share
 for cash      1,057,000     1,057       691,343             -         692,400

Issuance of stock
 at $0.0875 per share
 for financing
 fees            107,440       107         9,293             -           9,400

Issuance of stock
 at $.4453 per
 share for loan
 payment       2,124,701     2,125       845,457             -         847,582

Issuance of stock
 at $0.40 per
 share for
 services        229,808       230        91,693             -          91,923

Issuance of stock
 at $0.33 per
 share for loan
 extensions     598,382        599       193,967             -         194,466

Net loss for
 the year            -          -             -     (1,324,634)     (1,324,643)
             ----------    -------   -----------  ------------     -----------
Balance, June
 30, 1997    13,622,448    $13,623   $ 3,731,471  $ (1,798,055)    $ 1,947,039
             ----------    -------   -----------  ------------     -----------
</TABLE>







   The accompanying notes are an integral part of these financial
                             statements.

                                   5<PAGE> 7

FIRST AMERICAN SCIENTIFIC CORP.
STATEMENT OF STOCKHOLDERS' EQUITY
December 31, 1999
<TABLE>
<CAPTION>

                                                       Additional
                                     Common Stock      Paid-in
                              Shares         Amount    Capital
<S>                           <C>            <C>       <C>
Balance, June 30, 1997        13,622,448     $ 13,623  $ 3,731,471
Issuance of stock at $.05
 - $.158 per share for
 settlement of debt           27,919,250       27,919    1,606,268
Issuance of stock at $.02
 - $.20 per share for cash     3,000,000        3,000      237,000
Issuance of stock at $.25
 for purchase of patent and
 manufacturing rights          1,000,000        1,000      249,000
Issuance of stock at $.10 -
 $.227 per share for purchase
 of Bakersfield assets           223,000          223       31,377
Issuance of stock at $.117 -
 $.05 per share for settlement
 of royalty agreement          3,011,320        3,011      167,304
Exercise of stock, options
 at $.01 per share               550,000          550        4,950
Net loss for year                     -            -            -
                              -----------    --------  -----------
Balance, June 30, 1998         49,326,018      49,326    6,027,370

Issuance of stock for services
 at $.001 - $.025 per share     8,010,000       8,010       25,230
Issuance of stock for repayment
 of debt at $.01  - $.025
 per share                      3,160,000       3,160       96,506
Issuance of stock for license
 agreement at $.05 per share    1,000,000       1,000       49,000
Issuance of stock for cash at
 $.04 per share                 4,650,000       4,650      200,925
Stock subscriptions receivable         -           -            -
Net loss for year                      -           -            -
Foreign currency translation
 gain                                  -           -            -
                              -----------    --------  -----------
Balance June 30, 1999          66,146,018      66,146    6,399,031
                              -----------    --------  -----------
</TABLE>









   The accompanying notes are an integral part of these financial
                            statements.

                                6-a

<PAGE> 8

FIRST AMERICAN SCIENTIFIC CORP.
STATEMENT OF STOCKHOLDER'S EQUITY
December 31, 1999
<TABLE>
<CAPTION>
                                                   Accumulated
                       Subscriptions               Other          Total
                       & Options     Accumulated   Comprehensive  Stockholders'
                       Receivable    Deficit       Income         Equity
<S>                    <C>           <C>           <C>            <C>
Balance, June 30,1997  $      -      $ (1,798,055) $     -        $ 1,947,039

Issuance of stock at
 $.05 - $.158  per share
 for settlement of debt       -                -         -         1,634,187
Issuance of stock at
 $.02 - $.20 per
 share for cash          (40,000)              -         -           200,000
Issuance of stock at
 $.25 for purchase
 of patent and
 manufacturing rights         -                -         -           250,000
Issuance of stock at
 $.10 - $.227 per share
 for purchase of
 Bakersfield assets           -                -         -            31,600
Issuance of stock at $.117
 - $.05 per share for
 settlement of royalty
 agreement                    -                -         -           170,315
Exercise of stock options at
 $.01 per share           (5,500)              -         -                -

Net loss for year             -        (1,072,922)       -        (1,072,922)
                       ---------     ------------  --------      -----------
Balance, June 30, 1998   (45,500)      (2,870,977)       -         3,160,219

Issuance of stock for
 services at  $.001 -
 $.025 per share              -                -         -            33,240
Issuance of stock for
 repayment of debt at
 $.01 - $.025 per share       -                -         -            99,666
Issuance of stock for
 license agreement
 at $.05 per share            -                -         -            50,000
Issuance of stock for
 cash at $.04 per share       -                -         -           205,575
Stock subscriptions
 receivable               45,500               -         -            45,500
Net loss                       -        (1,011,095)       -         (968,932)
Foreign currency
 translation gain             -                -      2,954            2,954
                       ---------     ------------  --------      -----------
Balance,
 September 30, 1999    $      -      $ (3,882,072) $  2,954      $ 2,628,222
                       ---------     ------------  --------      -----------
</TABLE>

The accompanying notes are an integral part of these financial statements.

                                 6-b

<PAGE> 9

FIRST AMERICAN SCIENTIFIC CORP.
STATEMENT OF STOCKHOLDERS' EQUITY
December 31, 1999
<TABLE>
<CAPTION>

                                                       Additional
                                     Common Stock      Paid-in
                              Shares         Amount    Capital
<S>                           <C>            <C>       <C>
Balance June 30, 1999          66,146,018      66,146    6,399,031

Issuance of stock for
 debt settlement at
 $0.025 per share               5,600,000       5,600      134,809

Issuance of stock
 for settlement of
 technology debt
 at $0.05                       6,000,000       6,000      294,000

Issuance of stock for
 purchase of KDS machines
 at $0.05 per share             2,000,000       2,000       98,000

Issuance of stock for
 cash at $0.015 per share       3,000,000       3,000       42,000

Issuance of stock for
 cash at $0.01 per share        1,000,000       1,000        9,000

Issuance of stock for
 cash at $0.025 per share       5,500,000       5,500      132,000

Issuance of stock for
 cash at $0.05 per share        1,000,000       1,000       49,000

Issuance of stock for
 settlement of licence
 rights                         2,500,000       2,500           -

Issuance of stock for
 services $0.01 - $0.034        5,000,000       5,000       60,610

Net loss for period ending
 December 31, 1999
                              -----------    --------  -----------
Balance
 December 31, 1999             97,746,018    $ 97,746  $ 7,218,450
                              ===========    ========  ===========
</TABLE>







   The accompanying notes are an integral part of these financial
                            statements.

                                7-a

<PAGE> 10

FIRST AMERICAN SCIENTIFIC CORP.
STATEMENT OF STOCKHOLDER'S EQUITY
December 31, 1999
<TABLE>
<CAPTION>
                                                   Accumulated
                       Subscriptions               Other          Total
                       & Options     Accumulated   Comprehensive  Stockholders'
                       Receivable    Deficit       Income         Equity
<S>                    <C>           <C>           <C>            <C>
Balance
 June 30, 1999         $      -      $ (3,882,072)     $  2,954  $ 2,586,058


Issuance of stock for
 debt settlement at
 $0.025 per share              -              -         -       140,409

Issuance of stock
 for settlement of
 technology debt
 at $0.05                      -              -         -       300,000

Issuance of stock for
 purchase of KDS machines
 at $0.05 per share            -              -         -       100,000

Issuance of stock for
 cash at $0.015 per share      -               -         -        45,000

Issuance of stock for
 cash at $0.01 per share       -               -         -        10,000

Issuance of stock for
 cash at $0.025 per share      -               -         -       137,500

Issuance of stock for
 cash at $0.05 per share       -               -         -        50,000

Issuance of stock for
 settlement of licence
 rights                        -              -         -         2,500

Issuance of stock for
 services $0.01 - $0.034       -               -         -        65,610

Net Loss for period ending
 December 31, 1999             -        (116,089)      -       (116,089)
                         --------  -------------  --------  -----------
Balance
 December 31, 1999             -   $  (3,998,161) $ 2,954   $ 3,320,989
                         ========  =============  =======   ===========
</TABLE>





   The accompanying notes are an integral part of these financial statements.

                                 7-b

<PAGE> 11

FIRST AMERICAN SCIENTIFIC CORP.
STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
                                        Period Ended   Year Ended
                                        Dec 31, 1999   June 30, 1999
<S>                                     <C>            <C>
CASH FLOWS PROVIDED (USED) IN
 OPERATING ACTIVITIES
 Net income (loss)                      $ (113,670)    $ (1,011,095)
 Depreciation and amortization                  -           313,255
 Impairment of assets                           -           629,118
 Adjustments to reconcile net loss
  to net cash used by operations:
   Services paid by issuance of stock       11,360           33,240
   Decrease (Increase) in
    accounts receivable                         -
                                                            23,908
   Decrease (Increase) in inventory             -            5,500
   Decrease (Increase) in prepaid expenses      -               -
   Deposits                                     -            2,304
   (Decrease) Increase in accounts payable  (3,057)        (60,355)
   (Decrease) Increase in
    litigation reserve                          -               -
   Payment for shares for investment      (251,229)             -
   Payment on license agreements payable        -         (185,020)
                                        ----------     ------------
Net cash (used) in operating activities   (356,596)        (249,125)
                                        ----------     ------------
CASH FLOWS PROVIDED (USED) IN
 INVESTING ACTIVITIES

Net cash provided (used) in
 investing activities                           -                -
                                        ----------     ------------
CASH FLOWS PROVIDED (USED)
 IN FINANCING ACTIVITIES
  Borrowings                                24,820           80,467
  Payments on borrowings                        -           (12,360)
  Proceeds from sales of stock             381,241          205,575
                                        ----------     ------------
Net cash provided by
 financing activities                      406,061          273,682
                                        ----------     ------------
NET INCREASE (DECREASE) IN CASH         $   49,465     $     24,557
                                        ----------     ------------
</TABLE>





   The accompanying notes are an integral part of these financial
                            statements.

                                 8


<PAGE> 12

FIRST AMERICAN SCIENTIFIC CORP.
STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
                                        Period Ended   Year Ended
                                        Dec 31, 1999   June 30, 1999
<S>                                     <C>            <C>
NET INCREASE (DECREASE) IN CASH
 (Balance forward)                      $  49,465      $    24,557

CASH - Beginning of year                   25,690            1,133
                                        ---------      -----------
CASH - End of period                    $  75,155      $    25,690
                                        =========      ===========
SUPPLEMENTAL CASHFLOW DISCLOSURES
 Interest                               $      -       $     8,787

 Income Taxes                           $      -       $        -

NON-CASH INVESTING ACTIVITIES
 Common stock issued for purchase of
  fixed assets                          $ 100,000      $    31,600
 Common stock issued for payment on
  royalty agreements                    $      -       $   170,315
 Common stock issued for payment on
  license agreement payable             $ 302,000

NON-CASH FINANCING ACTIVITIES
 Common stock issued for payment on
  patents and manufacturing rights      $     500      $   250,000
 Common stock issued for
  services rendered                     $  11,360      $        -
 Common stock issued for exchange
  of debt                               $ 140,409      $ 1,634,187
 Common stock issued for payment
  on worldwide technology license       $     500      $        -
 Common stock issued for commissions    $      -       $    13,500
 Common stock issued for
  prepaid expenses                      $  53,500      $        -

</TABLE>
















   The accompanying notes are an integral part of these financial
                            statements.

                                 9
<PAGE> 13

FIRST AMERICAN SCIENTIFIC CORP.
NOTES TO THE FINANCIAL STATEMENTS
September 30, 1999
(Unaudited)

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS

First American Scientific Corp., (hereinafter "the Company"), was
incorporated in April 1995 under the laws of the State of Nevada
primarily for the purpose of manufacturing of rubber powder for
industrial fillers, and has acquired the rights to process and sell
industrial products such as gypsum, limestone, and sulfur.  The Company
maintains an office in Vancouver, British Columbia Canada.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

This summary of significant accounting policies of First American
Scientific Corp. is presented to assist in understanding the Company's
financial statements.  The financial statements and notes are
representations of the Company's management who are responsible for
their integrity and objectivity.  These accounting policies conform to
generally accepted accounting principles and have been consistently
applied in the preparation of the financial statements.

Going Concern
The accompanying financial statements have been prepared assuming that
the Company will continue as a going concern.

As shown in the accompanying financial statements, the Company has
incurred an accumulated deficit of $3,998,160 through Dec. 31, 1999,
and has a working capital deficit. The Company is currently putting
technology in place which will, if successful, mitigate these factors
which raise substantial doubt about the Company's ability to continue
as a going concern.  The financial statements do not include any
adjustments relating to the recoverability and classification of
recorded assets, or the amounts and classification of liabilities that
might be necessary in the event the Company cannot continue in
existence.

Management has established plans designed to increase the sales of the
Company's products.  Management intends to seek new capital from new
equity securities offerings that will provide funds needed to increase
liquidity, fund internal growth and fully implement its business plan.
















                                 10
<PAGE> 14

FIRST AMERICAN SCIENTIFIC CORP.
NOTES TO THE FINANCIAL STATEMENTS
September 30, 1999
(Unaudited)

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Accounting Method
The Company's financial statements are prepared using the accrual
method of accounting

Earnings (Loss) Per Share
In June 1999, the Company adopted Statement of Financial Accounting
Standards Statement (SFAS) No. 128, Earnings Per Share. Basic earnings
(loss) per share is computed using the weighted average number of
common shares outstanding.  Diluted net loss per share is the same as
basic net loss per share as the inclusion of common stock equivalents
would be antidilutive.

Cash and Cash Equivalents
For purposes of the Statement of Cash Flows, the Company considers all
short-term debt securities purchased with a maturity of three months or
less to be cash equivalents.

Provision for Taxes
At December 31, 1999, the Company had net operating accumulated losses
of $3,998,160.  No provision for taxes or tax benefit has been reported
in the financial statements, as there is not a measurable means of
assessing future profits or losses.

Use of Estimates
The process of preparing financial statements in conformity with
generally accepted accounting principles requires the use of estimates
and assumptions regarding certain types of assets, liabilities,
revenues, and expenses.  Such estimates primarily relate to unsettled
transactions and events as of the date of the financial statements.
Accordingly, upon settlement, actual results may differ from estimated
amounts.

Compensated Absences
Employees of the Company are entitled to paid vacation, paid sick days
and personal days off, depending on job classification, length of
service, and other factors.  It is impracticable to estimate the amount
of compensation for future absences, and, accordingly, no liability has
been recorded in the accompanying financial statements.  The Company's
policy is to recognize the costs of compensated absences when actually
paid to employees.  The Company has no employees and utilizes
consultants only at this time.











                                 11
<PAGE> 15

FIRST AMERICAN SCIENTIFIC CORP.
NOTES TO THE FINANCIAL STATEMENTS
September 30, 1999
(Unaudited)

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Year 2000
The Company, like other firms, could be adversely affected if the
computer systems used by it, its suppliers or customers do not properly
process and calculate date-related information and data from the period
surrounding and including January 1, 2000.  This is commonly known as
the "Year 2000" issue.  Additionally, this issue could impact
non-computer systems and devices such as production equipment.

At this time, because of the complexities involved in the issue,
management cannot provide absolute assurances that the Year 2000 issue
will not have an impact on the Company's operations.

The Company has reviewed its technology, including software and
hardware, and has determined that there will be no adverse effects to
the Company's operations regarding Year 2000 issues.  Management also
believes that Year 2000 issues should not adversely affect the ability
of its clients and customers to conduct business with the Company.  Any
costs associated with Year 2000 compliance are expensed when incurred.

Segment Reporting
The company adopted SFAS No. 131, "Disclosures about Segments of an
Enterprise and Related Information," in the fiscal year ended June 30,
1999.  SFAS No. 131 requires disclosures about products and services,
geographic areas and major customers.  The adoption of SFAS No. 131 did
not affect the Company's results of operation or financial position.
The Company's Bakersfield plant was not in operation during 1999,
therefore there is no segment information required.

Revenue and Cost Recognition
Revenues are recognized when products are delivered.

Costs include all direct material and labor costs and those indirect
costs related to the products.  Changes in job performance, job
conditions, and estimated profitability may result in revisions to
costs and income and are recognized in the period in which the
revisions are determined.

NOTE 3 - PROPERTY AND EQUIPMENT

Property and equipment are stated at cost.  Depreciation is provided
using the straight-line method over the estimated useful lives of the
assets.  The useful lives of property, plant and equipment for purposes
of computing depreciation are five to forty years. The following is a
summary of property, equipment and accumulated depreciation.








                                 12
<PAGE> 16

FIRST AMERICAN SCIENTIFIC CORP.
NOTES TO THE FINANCIAL STATEMENTS
September 30, 1999
(Unaudited)

NOTE 3 - PROPERTY AND EQUIPMENT - continued
<TABLE>
<CAPTION>

                                   Dec 31, 1999   June 30, 1999
<S>                                <C>            <C>
Ultrasound equipment               $    972,246   $    872,246
Plant assets and equipment              687,881        687,881
Office equipment                         23,916         23,916
Leasehold improvements                    5,476          5,476
Total assets                          1,689,519      1,589,519
Less accumulated depreciation          (327,567)      (327,567)
                                   $  1,361,952   $  1,261,952
</TABLE>
Depreciation and amortization expense for the year ended June 30, 1999
was $313,255. No depreciation has been taken in the current year. The
Company evaluates the recoverability of property and equipment when
events and circumstances indicate that such assets might be impaired.
The Company determines impairment by comparing the undiscounted future
cash flows estimated to be generated by these assets to their
respective carrying amounts.  During 1999, the Company suspended
operations at its Bakersfield location and determined that plant assets
were impaired by $629,118.

Maintenance and repairs are expensed as incurred.  Replacements and
betterments are capitalized.  The cost and related reserves of assets
sold or retired are removed from the accounts, and any resulting gain
or loss is reflected in results of operations.

Technology licenses, patents and manufacturing rights are stated at
cost.  Amortization is provided using the straight-line method over the
estimated useful lives of the assets, which is fifteen years.  The
following is a summary of technology licenses, patents and
manufacturing rights and accumulated amortization.
<TABLE>
<CAPTION>
                                        Dec  31, 1999  June 30, 1999
<S>                                     <C>            <C>
Technology license                      $ 1,905,500    $ 1,905,000
Patents and manufacturing rights            250,000        250,000
                                          2,155,500      2,155,000
Less accumulated amortization              (306,960)      (306,960)
                                        $ 1,848,540    $ 1,848,040
</TABLE>













                                 13
<PAGE> 17

FIRST AMERICAN SCIENTIFIC CORP.
NOTES TO THE FINANCIAL STATEMENTS
September 30, 1999
(Unaudited)

NOTE 4 - COMMON STOCK AND WARRANTS

On June 4, 1998, the Board of Directors authorized and increased common
stock from 50,000,000 to 100,000,000 authorized shares.

During the quarter ending Dec 31, 1999, the Company issued 5,000,000
shares of common stock for consulting, advertising and other services.
The Company valued these services at $65,610.  The Company issued
6,000,000 shares of common stock for settlement of technology debt,
valued at $300,000, 2,000,000 shares of common stock for fixed asset
additions, 2,500,000 shares of common stock for settlement of license
rights, and 16,100,000 shares of common stock for cash.

NOTE 5-STOCK OPTIONS

In September 1998, the Company adopted the First American Scientific
Corp. 1998 Directors and Officers Stock Option Plan, a non-qualified
plan.  This plan allows the Company to distribute up to 15,000,000
shares of common stock to officers, directors, employees and
consultants through the authorization of the Company's Board of
Directors.

In the year ending June 30, 1999, the Company issued 3,300,000 common
stock shares for the services of consultants.  The Company valued these
services at $3,300.

The fair value of each option granted is estimated on the grant date
using the Black-Scholes Option Price Calculation.  The following
assumptions were made in estimating fair value: risk-free interest rate
is 5% and expected life is 5 years.  During the year ending June 30,
1999, the Company issued 4,750,000 common stock options which were
exercised before year-end at an average price of $.019 per share.  The
strike price of these options exceeds the options' minimum value
calculated using the Black-Scholes model.  Accordingly, no compensation
costs have been recognized pursuant to Financial Accounting Standard
No.123.

NOTE 6 - RELATED PARTIES

Certain consultants who received common stock under the Company's
non-qualified stock option plan are Company directors and stockholders.
During the quarter ending December 31, 1999, 4,725,000 shares were
issued under the stock option plan to members of the board of directors
who provided services to the Company.










                                 14
<PAGE> 18

FIRST AMERICAN SCIENTIFIC CORP.
NOTES TO THE FINANCIAL STATEMENTS
September 30, 1999
(Unaudited)

NOTE 7 -  COMMITMENTS AND CONTINGENCIES

Lease Commitments
The Company owns no real property. The Company negotiated a  three-year
lease for 740 square feet with Morguard Investments that commenced
August 1, 1998 at a monthly rental of $1,000 at Suite 1003 - 409
Granville Street,  Vancouver BC

In May 1996, the Company signed a lease to rent facilities in
Bakersfield, California for the industrial processing of gypsum,
limestone and specialty products.  The lease, which required payments
of $2,000 per month, expired on April 14, 1998.  Negotiations, with a
proposed joint venture partner to take over this facility, are ongoing.
At the present time the Company is not utilizing the facility, except
for storage of equipment.  No rental payments have been made since the
expiration of this lease.  Although the lease required the Company to
carry insurance on the facility, the Company has elected to self-insure
this location until the facility re-opens.

Technology License
On June 22, 1995, the Company entered into a license agreement with
Spectrasonic Corp. (hereinafter "Spectrasonic"), a related party, for
the worldwide license to its unpatented Sonic Disintegration Equipment
(SDM) for use in rubber and glass recycling and disposal, for a period
of ninety-nine years.  The purchase price of this license and one SDM
machine was $550,000, with license rights valued at $250,000.  Since
this initial agreement, modifications have been made to the first SDM
machine, bringing its total cost to $440,740.

On February 22, 1996, the Company entered into an additional license
agreement with Spectrasonic for the worldwide license to its unpatented
Ultrasound Equipment for exclusive use in gypsum disintegration,
disposal, recycling, remanufacturing or manufacturing of used or new
raw materials.  The purchase price of this license and one SDM machine
for gypsum-related use was $775,000, with the parties agreeing that the
technology license is valued at $425,000 and the gypsum SDM machine is
valued at $350,000.

On May 17, 1996, the Company executed another agreement with
Spectrasonic for the worldwide licenses to equipment (as yet
unpatented) developed by Spectrasonic for use in disintegration,
disposal, recycling, remanufacturing or manufacturing "any and all
kinds of materials" for a period of ninety-nine years.  The purchase
price of this license was $1,230,000, which consisted of the Company
issuing to Spectrasonic 1,000,000 shares of First American common stock
(with an aggregate deemed value of $500,000) and agreeing to pay
$730,000 in varying installment amounts between June 30, 1996 and
January 2, 1997. The Company issued 1,000,000 common stock shares to
Spectrasonic in July 1996.





                                 15
<PAGE> 19

FIRST AMERICAN SCIENTIFIC CORP.
NOTES TO THE FINANCIAL STATEMENTS
September 30, 1999
(Unaudited)

NOTE 7 -  COMMITMENTS AND CONTINGENCIES - continued

At June 30, 1999, the balance owing on this agreement was $302,000 and
subsequent to the year end, a cash payment and issuance of common stock
retired the balance outstanding.

On July 2, 1997, the Company finalized negotiations with Spectrasonic
for all patents issued, to be issued or pending, including all data
pertaining to the patent process with respect to the Micronizing
Machine (SDM Machine) whose worldwide rights had been previously
acquired by the Company.  In the negotiations, Company acquired all
manufacturing rights applicable to the SDM machine technology.  The
Company has sole right and responsibility for manufacturing the
machinery.  Consideration to Spectrasonic will be the issuance of
1,000,000 common shares of the Company's stock at $0.25 per share plus
the payment of $500,000. This amount has now been settled by issuance
of common stock and the Company has the sole right and ownership of the
patents, and the manufacturing rights worldwide.

NOTE 8 - NOTES PAYABLE

On November 15, 1996, the Company entered into a loan agreement with
Huntingdon Limited in the amount of $100,000. This loan, including
accrued interest of $10,000, was settled for 2,200,000 shares of common
stock on March 20, 1998.

On April 30, 1996, the Company entered into a loan agreement with
Knowlton Capital, Inc. wherein the lender agreed to provide a revolving
line of credit, which matures upon the Company's completion of a
preferred share offering.  The loan agreement gave Knowlton Capital,
Inc. the option of converting its loan into First American common stock
at a deemed value of $0.075 per share on or before December 31, 1996.
During the year ended June 30, 1997, the Company obtained an extension
on this loan by the issuance of 398,836 shares of common stock, valued
at $131,617.  This loan, with an interest rate of 10% and an
outstanding principal balance of $790,229 at June 30, 1997, was secured
by a collateral mortgage on the Company's Bakersfield plant and other
assets.  During the year ended June 30, 1998, all debt to Knowlton
Capital, Inc. was converted to stock.

NOTE 9 - EXTRAORDINARY GAIN

Forgiveness of Debt
During 1999, the Company negotiated debt settlement agreements with
various suppliers and vendors whereby the terms of the original
agreements were amended.  These transactions resulted in an
extraordinary gain of $33,767.







                                 16
<PAGE> 20

FIRST AMERICAN SCIENTIFIC CORP.
NOTES TO THE FINANCIAL STATEMENTS
September 30, 1999
(Unaudited)


NOTE 10 - SUBSEQUENT EVENTS

In September 1999, the Company entered into an agreement with Video
Movie House.com Inc, ("VMH") a British Columbia company whereby the
Company acquired 100% of the common shares of VMH for a cash
consideration of $250,000.  The sum of $125,000 was paid to the VMH and
the balance paid November 30, 1999.  VMH possesses domain names, a web
page, and technology for the sale of videos, DVD's, and CD's through
the Internet.  VMH will become a wholly owned subsidiary of the
Company.

NOTE 11 - INVESTMENTS

In August 1999, the Company agreed to acquire 100% of the shares of
Video MovieHouse.com Inc. a company using video on demand technology
for videos, DVD's, CD's and related products. Terms included a payment
of $125,000 down payment and the balance, $125.000 due Nov 30, 1999.
All payments have been made.



































                                 17
<PAGE> 21

MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS

Quarter - Ending December 31, 1999

LIQUIDITY AND CAPITAL RESOURCES

     First American Scientific (the Company) was incorporated April 12,
1995 as a development stage company.  From May 1997 to June 1998 it
operated a pilot project in Bakersfield, California which confirmed
that the technology worked for industrial minerals, primarily gypsum.
A joint venture to operate the plant ended in dispute between the
parties and operation of the plant ceased. Steps are now underway to
resolve the matter.

     On December 1, 1999, the Company met all conditions of its
agreements with Ashford Holdings LTD to acquire all patent rights to
the technology, to acquire full ownership of the equipment located in
Bakersfield, California to cancel future royalty obligations of
US$450,000 and to retire the remaining debt of US$302,000 owed the
patent holders. With this complete, the Company has irrevocable clear
title to the KDS patents and technology.

     On November 30, 1999 the Company completed the purchase 100% of
the shares of VMH VideoMovieHouse.com Inc. By making the final payment
of US$125,000 and VMH VideoMovieHouse.com Inc. is now a fully owned
subsidiary of the Company.  Web site development is now ongoing.

     The Company's only remaining liabilities (other than a US$24,820
loan from a director which has subsequently been repaid) are the
outstanding accounts payable of US$265,004 incurred from the
Bakersfield operation. Settlement negotiations and counterclaims are
currently underway.

     The company currently has US$75,155 cash on hand and has
sufficient liquidity to maintain its operation. It will, however,
continue to have a need for capital to advance its projects and plans
to actively pursue fund rasing activities, either by way of loans, sale
of stock or a combination of both.

RESULTS OF OPERATIONS - QUARTER ENDED DECEMBER 31, 1999

     The Company did not generate any revenue during this quarter, but
has been focusing its efforts on reducing liabilities, resolving
outstanding legal issues and developing a market strategy and business
plan. The Company is conscious of its operating expenses and is
carefully managing its resources.

     Phase I of the research and development funded by the "Radian
Award Program" in Ireland was completed and it has been proven that the
technology works in processing sludge at low volumes. Phase II research
is now underway to attempt to refine the process to increase throughput
volumes to commercially viable levels.







<PAGE> 22

     Plans to move the equipment in Tonasket, Washington to Vancouver,
British Columbia, Canada have been finalized for February 2000. The new
location will be used as a demonstration site and sales office. Plans
to relocate the equipment from Bakersfield to a mining site in Nevada
are nearing completion.

INFLATION

     Inflation has not been a factor effecting currant operations, and
is not expected to have any material effect on operations in the near
future.

FOREIGN OPERATIONS

     The Company rents office space in Vancouver, British Columbia,
Canada which serves as the corporate and administrative offices.
Administration site and sales office will be opened in the Vancouver
area sometime in the third quarter.

EXHIBIT INDEX

Exhibit No.    Description

27             Financial Data Schedule





































<PAGE> 23

                          SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on   its
behalf by the undersigned, thereunto duly authorized.

     Dated this 14th day of February, 2000.


                         FIRST AMERICAN SCIENTIFIC CORP.
                         (the "Registrant")


                         BY:  /s/ C.L. Kantonen
                              C.L. Kantonen, President,
                              Secretary/Treasurer, Chief Financial
                              Officer and a Member of the Board of
                              Directors